1. Home
  2. FSP vs CMPX Comparison

FSP vs CMPX Comparison

Compare FSP & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.98

Market Cap

120.3M

Sector

Real Estate

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.18

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
CMPX
Founded
1981
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.3M
752.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FSP
CMPX
Price
$0.98
$5.18
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$13.44
AVG Volume (30 Days)
688.0K
1.9M
Earning Date
10-28-2025
11-05-2025
Dividend Yield
4.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,497,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$0.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$1.33
52 Week High
$2.21
$5.86

Technical Indicators

Market Signals
Indicator
FSP
CMPX
Relative Strength Index (RSI) 37.48 55.26
Support Level $0.90 $5.09
Resistance Level $0.99 $5.44
Average True Range (ATR) 0.05 0.34
MACD 0.01 -0.05
Stochastic Oscillator 47.04 41.59

Price Performance

Historical Comparison
FSP
CMPX

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: